MicroRNA‐21 was a promising biomarker for lung carcinoma diagnosis: An update meta‐analysis
Abstract Objective To investigate the diagnostic performance of microRNA‐21 detected in serum or sputum as a biomarker for lung carcinoma identification through pooling the open published data. Methods Clinical diagnostic studies related to microRNA‐21 as a biomarker for lung carcinoma identificatio...
Main Authors: | Haiyan Wang, Jia Xu, Ling Ding |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-02-01
|
Series: | Thoracic Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1111/1759-7714.14242 |
Similar Items
-
MicroRNA-21 and microRNA-30c as diagnostic biomarkers for prostate cancer: a meta-analysis
by: Zhou H, et al.
Published: (2019-03-01) -
Circulating MicroRNAs as Promising Diagnostic Biomarkers for Patients With Glioma: A Meta-Analysis
by: Jimin He, et al.
Published: (2021-02-01) -
MicroRNA-21 as a potential biomarker for detecting esophageal carcinoma in Asian populations: a meta-analysis
by: Zheng Han, et al.
Published: (2022-09-01) -
MicroRNA-21 as a biomarker for ovarian cancer detection
by: Aprilia Indra Kartika, et al.
Published: (2018-06-01) -
MicroRNA‐based biomarkers for diagnosis of non‐small cell lung cancer (NSCLC)
by: Jipei Liao, et al.
Published: (2020-03-01)